Nucleo CMP Forte powder lyophilized for solution for injection

Страна: Армения

Язык: английский

Источник: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

Активный ингредиент:

cytidine-5-disodium monophosphate + (uridine-5-trisodium triphosphate, uridine-5-disodium diphosphate, uridine-5-disodium monophosphate)

Доступна с:

Ferrer Internacional

код АТС:

առկա չէ (N07XX)

ИНН (Международная Имя):

cytidine-5-disodium monophosphate + (uridine-5-trisodium triphosphate, uridine-5-disodium diphosphate, uridine-5-disodium monophosphate)

дозировка:

10mg+ 6mg

Фармацевтическая форма:

powder lyophilized for solution for injection

Штук в упаковке:

(3) ampoules, (3) solvent in ampoules 2ml

Тип рецепта:

Prescription

Статус Авторизация:

Registered

Дата Авторизация:

2018-04-17

Характеристики продукта

NUCLEO CMP FORTE INJECTIONS
SUMMARY PRODUCT CHARACTERISTICS
1. NAME OF THE MEDICINAL PRODUCT:
NUCLEO CMP FORTE injections
2. QUALITATIVE AND QUANTITATIVE COMPOSITION.
Composition:
Per lyophilized ampoule:
Cytidine-5’-disodium monophosphate (CMP disodium salt)… 10 mg
Uridine-5’-trisodium triphosphate (UTP trisodium salt)
Uridine-5’-disodium diphosphate (UDP disodium salt)
Uridine-5’-disodium monophosphate (UMP disodium salt)
on the whole ………………………………… 6 mg
(equivalent to 2.660 mg of Uridine )
Excipient
…………………………………………………….
q.s.
Per ampoule of solvent:
Sodium chloride
Aqueous vehicle, q.s. 2 ml.
3. PHARMACEUTICAL FORM:
- Ampoules containing a lyophilised powder in the form of pastille,
white-coloured and
hygroscopic.
4. CLINICAL PARTICULARS:
4.1. THERAPEUTICAL INDICATIONS:
Treatment
of
neuropathies
of
osteoarticular
(sciatica,
radiculitis,
etc.),
metabolic
(diabetic, alcoholic polyneuritis, etc.), infectious (herpes zoster)
origin, and a frigore.
Neuralgia of the Facial, Trigeminal, Intercostal, Lumbago.
4.2. POSOLOGY AND METHOD OF ADMINISTRATION:
- Nucleo CMP Forte injections is administered by intramuscular route.
Adults: 1 injection daily by intramuscular route.
Children: 1 injection every 2 days by intramuscular route.
4.3. CONTRAINDICATIONS:
Not known. Unless that there exists an allergy to any of the
components.
4.4. SPECIAL WARNINGS AND PRECAUTIONS FOR USE:
Introduce the whole content of the ampoule of solvent into the
lyophilised ampoule, stir
till completely dissolving the content of the latter. Inject by
intramuscular route.
4.5. INTERACTIONS WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF
INTERACTION:
Not known.
4.6. PREGNANCY AND LACTATION:
Its use during pregnancy is not contraindicated. However, it is
recommended that the
dosage pattern is established by the physician.
4.7. EFFECTS ON THE ABILITY TO DRIVE AND USE MACHINES
Not applicable
4.8. UNDESIRABLE EFFECTS:
Have not been described, but if any adverse reaction attributab